Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2018

01-09-2018 | Editorial

Oesophageal Squamous Dysplasia

Authors: Michael Auld, Havish Srinath, Eshwarshanker Jeyarajan

Published in: Journal of Gastrointestinal Cancer | Issue 3/2018

Login to get access

Excerpt

Squamous cell carcinoma (SCC) of the oesophagus is the most common neoplasia of the oesophagus worldwide [1]. In Australia, the incidence of oesophageal SCC is approximately 1 in 100,000 with males having a higher predilection [2]. The diagnosis is predominantly through endoscopic examination of the oesophagus. The overall incidence of oesophageal SCC has been trending downward over the last several decades [3, 4]. Western countries, in particular, have lower rates with some South African and Middle Eastern countries experiencing rates exceeding 100 in 100,000 [3]. Males are diagnosed with SCC in a ratio upwards of eight to one [4]. It represents a significant disease burden, associated with substantial morbidity, quality of life and a poor prognosis. Oesophageal cancer is graded by the TNM system which divides the carcinoma based on the depth of invasion through mucosa, submucosa and into adjacent structures [5]. …
Literature
1.
go back to reference Evans J, Early D, Chandraskhara V, et al. The role of endoscopy in the assessment and treatment of oesophageal cancer. Gastrointest Endosc. 2013;77:328–34.CrossRefPubMed Evans J, Early D, Chandraskhara V, et al. The role of endoscopy in the assessment and treatment of oesophageal cancer. Gastrointest Endosc. 2013;77:328–34.CrossRefPubMed
2.
go back to reference Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381–7.CrossRefPubMed Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381–7.CrossRefPubMed
3.
go back to reference Messman H. Squamous cell cancer of the oesophagus. Best Pract Res Clin Gastroenterol. 2001;15:249–65.CrossRef Messman H. Squamous cell cancer of the oesophagus. Best Pract Res Clin Gastroenterol. 2001;15:249–65.CrossRef
4.
go back to reference Yong E, Han XP, Watson D, et al. Outcome following surgery for squamous cell carcinoma of the oesophagus. ANZJSurg. 2009;79:724–8. Yong E, Han XP, Watson D, et al. Outcome following surgery for squamous cell carcinoma of the oesophagus. ANZJSurg. 2009;79:724–8.
5.
go back to reference Rice T, Patil D, Blackstone E. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothoracic Surg. 2017;6:119–30.CrossRef Rice T, Patil D, Blackstone E. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothoracic Surg. 2017;6:119–30.CrossRef
6.
go back to reference Chen S, Zhou K, Yang L, Ding G, Li H. Racial differences in esophageal squamous cell carcinoma: incidence and molecular features. Biomed Res Int. 2017;2017:1–9. Chen S, Zhou K, Yang L, Ding G, Li H. Racial differences in esophageal squamous cell carcinoma: incidence and molecular features. Biomed Res Int. 2017;2017:1–9.
7.
go back to reference Deng J, Chen H, Zhou D, et al. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations. Nat Commun. 2017;8:1–9.CrossRef Deng J, Chen H, Zhou D, et al. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations. Nat Commun. 2017;8:1–9.CrossRef
9.
go back to reference Alsobahi F, Collis S, Hunter K. The role of Fanconi Anaemia pathway in sporadic non-FA associated head and neck squamous cell carcinoma. Eur J Cancer. 2016;61:S35.CrossRef Alsobahi F, Collis S, Hunter K. The role of Fanconi Anaemia pathway in sporadic non-FA associated head and neck squamous cell carcinoma. Eur J Cancer. 2016;61:S35.CrossRef
10.
go back to reference Tipples K, Raouf S. Treatment of oesophageal squamous cell carcinoma in a patient with Fanconi anaemia. Clin Oncol. 2008;3:383–4.CrossRef Tipples K, Raouf S. Treatment of oesophageal squamous cell carcinoma in a patient with Fanconi anaemia. Clin Oncol. 2008;3:383–4.CrossRef
11.
go back to reference Bass A, Laird P, Shmulevich I. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;12:169–75. Bass A, Laird P, Shmulevich I. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;12:169–75.
12.
go back to reference Petrick J, Wyss A, Butler A. Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis. Br J Cancer. 2014;110:2369–77.CrossRefPubMedPubMedCentral Petrick J, Wyss A, Butler A. Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis. Br J Cancer. 2014;110:2369–77.CrossRefPubMedPubMedCentral
13.
go back to reference Siewert J, Ott K. Are squamous and adenocarcinomas of the oesophagus the same disease? Semin Radiat Oncol. 2007;17:38–44.CrossRefPubMed Siewert J, Ott K. Are squamous and adenocarcinomas of the oesophagus the same disease? Semin Radiat Oncol. 2007;17:38–44.CrossRefPubMed
14.
go back to reference Liu X, Zhang M, Ying S, Zhang C, Lin R, Zheng J, et al. Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma. Gastroenterology. 2017;153:166–77.CrossRefPubMed Liu X, Zhang M, Ying S, Zhang C, Lin R, Zheng J, et al. Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma. Gastroenterology. 2017;153:166–77.CrossRefPubMed
15.
go back to reference Smyth E, Lagergren J, Fitzgerald R, Lordick F, Shah M, Lagergren P, et al. Oesophageal cancer. Nature. 2017;3:1–21. Smyth E, Lagergren J, Fitzgerald R, Lordick F, Shah M, Lagergren P, et al. Oesophageal cancer. Nature. 2017;3:1–21.
16.
go back to reference Siewert J, Stein H, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western World. Ann Surg. 2001;234:360–7.CrossRefPubMedPubMedCentral Siewert J, Stein H, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western World. Ann Surg. 2001;234:360–7.CrossRefPubMedPubMedCentral
17.
go back to reference Haidry R, Butt M, Dunn J, et al. Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry. World J Gastroenterol. 2013;19:6011–9.CrossRefPubMedPubMedCentral Haidry R, Butt M, Dunn J, et al. Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry. World J Gastroenterol. 2013;19:6011–9.CrossRefPubMedPubMedCentral
18.
go back to reference Mannath J, Ragunath K. Endoscopic mucosal resection: who and how? Ther Adv Gastroenterol. 2010;4:275–82.CrossRef Mannath J, Ragunath K. Endoscopic mucosal resection: who and how? Ther Adv Gastroenterol. 2010;4:275–82.CrossRef
19.
go back to reference Dutton S, Ferry D, Blazeby J, et al. Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial. Lancet Oncol. 2014;15:894–904.CrossRefPubMed Dutton S, Ferry D, Blazeby J, et al. Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial. Lancet Oncol. 2014;15:894–904.CrossRefPubMed
20.
go back to reference Song L, Wilson B. Endoscopic detection of early upper GI cancers. Best Pract Res Clin Gastroenterol. 2005;19:833–56.CrossRef Song L, Wilson B. Endoscopic detection of early upper GI cancers. Best Pract Res Clin Gastroenterol. 2005;19:833–56.CrossRef
21.
go back to reference Lao-Sirieix P, Fitzgerald R. Screening for oesophageal cancer. Nature. 2012;9:278–86. Lao-Sirieix P, Fitzgerald R. Screening for oesophageal cancer. Nature. 2012;9:278–86.
22.
go back to reference Evans J, Early D, Fukami N. The role of endoscopy in Barretts oesophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76:1087–94.CrossRefPubMed Evans J, Early D, Fukami N. The role of endoscopy in Barretts oesophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76:1087–94.CrossRefPubMed
23.
go back to reference Walker M, Harris A, Edwards G, Talley N. A GP primer for understanding upper gastrointestinal tract biopsy reports. AFP. 2015;44:706–11.PubMed Walker M, Harris A, Edwards G, Talley N. A GP primer for understanding upper gastrointestinal tract biopsy reports. AFP. 2015;44:706–11.PubMed
24.
go back to reference Doi T, Piha-Paul SA, Jalal SI, Mai-Dang H, Saraf S, Koshiji M, et al. Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475). J Clin Oncol. 2016;34(4_suppl):7-7. Doi T, Piha-Paul SA, Jalal SI, Mai-Dang H, Saraf S, Koshiji M, et al. Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475). J Clin Oncol. 2016;34(4_suppl):7-7.
25.
go back to reference Kang Y, Satoh T, Ryu M, et al. Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastro-esophageal junction cancer (AGC): a double-blinded, randomized, phase III trial. J Clin Oncol. 2017;35:2–2.CrossRef Kang Y, Satoh T, Ryu M, et al. Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastro-esophageal junction cancer (AGC): a double-blinded, randomized, phase III trial. J Clin Oncol. 2017;35:2–2.CrossRef
Metadata
Title
Oesophageal Squamous Dysplasia
Authors
Michael Auld
Havish Srinath
Eshwarshanker Jeyarajan
Publication date
01-09-2018
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2018
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0122-3

Other articles of this Issue 3/2018

Journal of Gastrointestinal Cancer 3/2018 Go to the issue